Roderick T. Bunch

1.7k total citations · 1 hit paper
30 papers, 1.4k citations indexed

About

Roderick T. Bunch is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Roderick T. Bunch has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Roderick T. Bunch's work include Carcinogens and Genotoxicity Assessment (8 papers), DNA Repair Mechanisms (5 papers) and Molecular Biology Techniques and Applications (4 papers). Roderick T. Bunch is often cited by papers focused on Carcinogens and Genotoxicity Assessment (8 papers), DNA Repair Mechanisms (5 papers) and Molecular Biology Techniques and Applications (4 papers). Roderick T. Bunch collaborates with scholars based in United States, Germany and Sweden. Roderick T. Bunch's co-authors include Alan Eastman, Carl L. Alden, Kent Thudium, Alan J. Korman, Mark Selby, Dale L. Morris, Diane Feingersh, M. S. Srinivasan, Sujata Singh and Minhua Han and has published in prestigious journals such as Biochemical Pharmacology, Journal of Histochemistry & Cytochemistry and Toxicology and Applied Pharmacology.

In The Last Decade

Roderick T. Bunch

29 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates

2014 472 citations Changyu Wang, Kent Thudium et al. Cancer Immunology Research profile →

Peers

Roderick T. Bunch

ONCOL

IMMUN

PRM

Jisong Cui United States

Saswati Hazra United States

Miriam Falzon United States

Andrew E. Place United States

Audrey Sirvent France

Brian Bolognese United States

Glen S. Germain United States

Moses M. Kasembeli United States

Lubing Gu United States

Wei‐Tien Tai Taiwan

Jisong Cui United States

Roderick T. Bunch

751 ×1.0

ONCOL

559 ×0.9

246 ×0.9

IMMUN

130 ×0.9

137 ×0.9

PRM

Citations per year, relative to Roderick T. Bunch Roderick T. Bunch (= 1×) peers Jisong Cui

Countries citing papers authored by Roderick T. Bunch

Since Specialization

Citations

This map shows the geographic impact of Roderick T. Bunch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roderick T. Bunch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roderick T. Bunch more than expected).

Fields of papers citing papers by Roderick T. Bunch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roderick T. Bunch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roderick T. Bunch. The network helps show where Roderick T. Bunch may publish in the future.

Co-authorship network of co-authors of Roderick T. Bunch

This figure shows the co-authorship network connecting the top 25 collaborators of Roderick T. Bunch. A scholar is included among the top collaborators of Roderick T. Bunch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roderick T. Bunch. Roderick T. Bunch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thudium, Kent, Mark Selby, Julie A. Zorn, et al.. (2022). Preclinical Characterization of Relatlimab, a Human LAG-3–Blocking Antibody, Alone or in Combination with Nivolumab. Cancer Immunology Research. 10(10). 1175–1189. 55 indexed citations

Gamse, Joshua T., et al.. (2020). Decreased immune response in monkeys administered a human T-effector cell agonist (OX40) antibody. Toxicology and Applied Pharmacology. 409. 115285–115285. 4 indexed citations

Thompson, Kary E., et al.. (2019). Allogeneic murine pregnancy models for assessing the developmental effects of immune‐stimulating antibodies: Challenges in reproducibility. Birth Defects Research. 111(16). 1178–1191. 3 indexed citations

Guha, Mausumee, James K. Hennan, Damir Simic, et al.. (2017). In vitro and in vivo evaluation of dasatinib and imatinib on physiological parameters of pulmonary arterial hypertension. Cancer Chemotherapy and Pharmacology. 79(4). 711–723. 12 indexed citations

Wang, Faye, Jae Kwagh, Megan K. Fuller, et al.. (2016). Effects of BMS-986094, a Guanosine Nucleotide Analogue, on Mitochondrial DNA Synthesis and Function. Toxicological Sciences. 153(2). 396–408. 10 indexed citations

Bunch, Roderick T., et al.. (2015). MicroRNA as biomarkers of mitochondrial toxicity. Toxicology and Applied Pharmacology. 312. 26–33. 10 indexed citations

Wang, Changyu, Kent Thudium, Minhua Han, et al.. (2014). In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates. Cancer Immunology Research. 2(9). 846–856. 472 indexed citations breakdown →

Vleet, Terry R. Van, Damir Simic, Theodora W. Salcedo, et al.. (2014). d‐α‐tocopheryl polyethylene glycol 1000 succinate‐containing vehicles provide no detectable chemoprotection from oxidative damage. Journal of Applied Toxicology. 35(7). 791–798. 1 indexed citations

Simic, Damir, Emily R. Haines, Aiqing He, et al.. (2013). MicroRNA changes associated with atypical CYP1A1 inducer BMS-764459. Toxicology. 311(3). 169–177. 3 indexed citations

10.

Simic, Damir, et al.. (2013). Determination of Relative Notch1 and γ-Secretase-Related Gene Expression in Puromycin-Treated Microdissected Rat Kidneys. Gene Expression. 16(1). 39–47. 2 indexed citations

11.

Simic, Damir, et al.. (2011). An alternative method for high throughput RNA isolation from whole blood. 3(4). 74–76.

12.

Kramer, Jeffrey A., Sandra W. Curtiss, Kyle L. Kolaja, et al.. (2004). Acute Molecular Markers of Rodent Hepatic Carcinogenesis Identified by Transcription Profiling. Chemical Research in Toxicology. 17(4). 463–470. 43 indexed citations

13.

Kramer, Jeffrey A., Eric A.G. Blomme, Roderick T. Bunch, et al.. (2003). Transcription Profiling Distinguishes Dose-Dependent Effects in the Livers of Rats Treated with Clofibrate. Toxicologic Pathology. 31(4). 417–431. 39 indexed citations

14.

Oshiro, Y., et al.. (2001). Morphological Transformation of Syrian Hamster Embryo Cells at pH 6.7 by Bemitradine, a Nongenotoxic Carcinogen. PubMed. 14(2). 121–127. 1 indexed citations

15.

Opsahl, Alan, et al.. (2001). Effect of the Storage Period of Paraffin Sections on the Detection of mRNAs by In Situ Hybridization. Journal of Histochemistry & Cytochemistry. 49(7). 927–928. 16 indexed citations

16.

Bunch, Roderick T., David A. Gewirtz, & Lawrence F. Povirk. (1995). Ionizing Radiation-induced DNA Strand Breakage and Rejoining in Specific Genomic Regions as Determined by an Alkaline Unwinding/Southern Blotting Method. International Journal of Radiation Biology. 68(5). 553–562. 21 indexed citations

17.

Bunch, Roderick T., Lawrence F. Povirk, Michael S. Orr, et al.. (1994). Influence of amsacrine (m-AMSA) on bulk and gene-specific DNA damage and c-myc expression in MCF-7 breast tumor cells. Biochemical Pharmacology. 47(2). 317–329. 18 indexed citations

18.

Gewirtz, David A., Michael S. Orr, Frank A. Fornari, et al.. (1993). Dissociation between bulk damage to DNA and the antiproliferative activity of teniposide (VM-26) in the MCF-7 breast tumor cell line: evidence for induction of gene-specific damage and alterations in gene expression.. PubMed. 53(15). 3547–54. 17 indexed citations

19.

Ellis, Amy, Roderick T. Bunch, Joyce K. Randolph, et al.. (1992). Components of intrinsic drug resistance in the rat hepatoma. Biochemical Pharmacology. 43(2). 331–342. 8 indexed citations

20.

Bunch, Roderick T., David A. Gewirtz, & Lawrence F. Povirk. (1992). A combined alkaline unwinding/Southern blotting assay for measuring low levels of cellular DNA breakage within specific genomic regions.. PubMed. 4(1). 7–15. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact